METHOD FOR IMPROVING THERMOSTABILITY OF PHYTASE, MUTANT AND USE
20250388881 ยท 2025-12-25
Inventors
- Huoqing Huang (Beijing, CN)
- Tao Tu (Beijing, CN)
- Qian Wang (Beijing, CN)
- Bin YAO (Beijing, CN)
- Huiying Luo (Beijing, CN)
- Yingguo Bai (Beijing, CN)
- Yuan Wang (Beijing, CN)
- Xiaoyun Su (Beijing, CN)
- Yaru Wang (Beijing, CN)
- Jie Zhang (Beijing, CN)
- Xing Qin (Beijing, CN)
- Xiaolu WANG (Beijing, CN)
- Honglian ZHANG
- Huimin YU (Beijing, CN)
Cpc classification
International classification
Abstract
The present invention relates to the field of genetic engineering, particularly to method for improving thermo-stability of phytase, mutant and use. The present invention introduces a series of mutations to the phytase APPAmut4, which may involve introducing disulfide bonds, reducing the free energy of unfolding, optimizing the key residues in the coevolution process, and significantly improving the thermal stability of the phytase. Among the mutants of the present invention, the optimal mutant APPAmut9 retains about 70% of its activity after being treated for 5 minutes at 100 C., while the phytase APPAmut4 has already been inactivated. Therefore, the present invention overcomes the shortcomings of the prior art and provides phytase mutants with high thermal stability suitable for wide application in fields such as energy, food, and feed.
Claims
1. A phytase mutant having phytase activity and comprising the amino acid sequence of SEQ ID NO:1, except A corresponding to position 57 and A corresponding to position 103 of SEQ ID NO: 1 are replaced with C respectively, or, G corresponding to position 101 and V corresponding to position 116 of SEQ ID NO: 1 are replaced with C respectively, or R corresponding to position 271 and E corresponding to position 413 of SEQ ID NO: 1 are replaced with C respectively, or R corresponding to position 353 and L corresponding to position 401 of SEQ ID NO: 1 are replaced with C respectively, or A corresponding to position 147 and Y corresponding to position 268 of SEQ ID NO: 1 are replaced with C respectively, and wherein the phytase mutant has the improved thermal stability as compared to a phytase consisting of the amino acid sequence of SEQ ID NO: 1.
2. The phytase mutant according to claim 1, wherein said phytase mutant comprises the amino acid sequence of SEQ ID NO:1, further except that G corresponding to position 65 is replaced with R, or, E corresponding to position 282 of SEQ ID NO: 1 is replaced with L or, G corresponding to position 365 of SEQ ID NO: 1 is replaced with D, or D corresponding to position 133 of SEQ ID NO: 1 is replaced with E, or R corresponding to position 382 of SEQ ID NO: 1 is replaced with I, or, S corresponding to position 393 of SEQ ID NO: 1 is replaced with I.
3. The phytase mutant according to claim 1, wherein said phytase mutant comprises the amino acid sequence of SEQ ID NO:2, or SEQ ID NO:3, or SEQ ID NO: 4.
4. A polynucleotide comprising a nucleotide sequence encoding the phytase mutant of claim 1.
5. A DNA construct comprising the polynucleotide of claim 4.
6. An isolated recombinant cell comprising the polynucleotide of claim 4.
7. A method of improving the thermal stability of a phytase comprising an amino acid of SEQ ID NO:1, wherein said method comprising the step of replacing A corresponding to position 57 of SEQ ID NO:1 with C, and A corresponding to position 103 of SEQ ID NO:1 with C, or, replacing G corresponding to position 101 of SEQ ID NO:1 with C, and V corresponding to position 116 of SEQ ID NO:1 with C, or, replacing R corresponding to position 271 of SEQ ID NO:1 with C, and E corresponding to position 413 of SEQ ID NO:1 with C, or, replacing R corresponding to position 353 of SEQ ID NO: 1 with C, and L corresponding to position 401 of SEQ ID NO:1 with C, or, replacing A corresponding to position 147 of SEQ ID NO:1 with C, and Y corresponding to position 268 of SEQ ID NO:1 with C.
8. The method according to claim 7, wherein said method further comprises the step of replacing G corresponding to position 65 with R, or, replacing E corresponding to position 282 of SEQ ID NO: 1 with L, or, replacing G corresponding to position 365 of SEQ ID NO: 1 with D, or, replacing D corresponding to position 133 of SEQ ID NO: 1 with E, or, replacing R corresponding to position 382 of SEQ ID NO: 1 with I, or, replacing S corresponding to position 393 of SEQ ID NO: 1 with I.
9. The method according to claim 7, wherein said method comprises the step of replacing A corresponding to position 57, A corresponding to position 103, G corresponding to position 101, V corresponding to position 116, R corresponding to position 271, E corresponding to position 413, R corresponding to position 353, L corresponding to position 401, A corresponding to position 147, and Y corresponding to position 268 of SEQ ID NO:1 with C, respectively.
10. The method according to claim 9, wherein said method further comprises the steps of replacing G corresponding to position 65 with R, replacing E corresponding to position 282 of SEQ ID NO: 1 with L, and replacing G corresponding to position 365 of SEQ ID NO: 1 with D.
11. The method according to claim 10, wherein said method further comprises the steps of replacing D corresponding to position 133 of SEQ ID NO: 1 with E, replacing R corresponding to position 382 of SEQ ID NO: 1 with I, and replacing S corresponding to position 393 of SEQ ID NO: 1 with I.
12. A use of the phytase mutant of claim 1 to hydrolyzing the phytic acid.
Description
BRIEF DESCRIPTIONS OF THE DRAWINGS
[0072]
[0073]
[0074]
[0075]
[0076]
EMBODIMENT
Test Materials and Reagents:
[0077] 1. Strains and vectors: Pichia pastoris GS115 and expressing vector pPICZA; [0078] 2. Enzymes and other biochemical reagents: Endonucleases; [0079] 3. Medium: [0080] (1) Low-salt LB (LLB) for Escherichia coli: 1% peptone, 0.5% yeast extract, 0.5% NaCL, pH natural), [0081] (2) Pichia pastoris YPD medium: 1% yeast extract, 2% peptone, 2% glucose, 7.0; [0082] (3) BMGY medium: 1% yeast extract, 2% peptone, 1% glycerol, 1.34% YNB, 0.00004% Biotin, pH 7.0; [0083] (4) BMMY medium: 1% yeast extract, 2% peptone, 0.5% methanol, 1%, 1.34% YNB, 0.00004% Biotin, pH 7.0.
[0084] Suitable biology laboratory methods not particularly mentioned in the examples as below can be found in Sambrook, et al. (Molecular Cloning: A Laboratory Manual. 2nd, ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989), and other kit laboratory manuals.
[0085] Method for determining phytase activity: Diluting the enzyme solution with 0.1 mol/L HAc NaAc buffer containing 0.05% BSA and 0.05% Triton X-100 at pH 5.5, adding 100 L of the diluted enzyme solution to 900 L of sodium phytate substrate being prepared with 0.1 mol/L HAc NaAc buffer at pH 5.5, reacting at 37 C. for 10 minutes, adding 1 mL of 10% (W/V) TCA to terminate the reaction, adding 1 mL of colorimetric solution containing 1% (W/V) ammonium molybdate tetrahydrate, 3.2% (V/V) concentrated sulfuric acid, 7.32% (W/V) ferrous sulfate for color development, while the control is added with TCA and mixed well before adding the enzyme solution to denature the enzyme, and measuring the OD value under 700 nm light absorption and calculating the enzyme activity.
Example 1 Site-Directed Mutation of the Phytase APPAmut4
[0086] The site directed mutations were performed with the primers as list in the table 1 using the mutagenesis kit.
[0087] Firstly, the amino acid sequence of phytase APPAmut4 derived from Yersinia intermedia was performed the mutations of replacing A corresponding to position 57 of SEQ ID NO:1 with C, and A corresponding to position 103 of SEQ ID NO:1 with C to obtain the mutant A57C/A103C, or [0088] replacing G corresponding to position 101 of SEQ ID NO:1 with C, and V corresponding to position 116 of SEQ ID NO:1 with C to to obtain the mutant G101C/V116C, or, [0089] replacing R corresponding to position 271 of SEQ ID NO:1 with C, and E corresponding to position 413 of SEQ ID NO:1 with C to obtain the mutant R271C/E413C, or, [0090] replacing R corresponding to position 353 of SEQ ID NO:1 with C, and L corresponding to position 401 of SEQ ID NO:1 with C to obtain the mutant R353C/L401C, or [0091] replacing A corresponding to position 147 of SEQ ID NO:1 with C, and Y corresponding to position 268 of SEQ ID NO:1 with C to obtain the mutant R353C/L401C.
[0092] Secondly, The amino acid sequence of phytase APPAmut4 derived from Yersinia intermedia was performed the mutations of replacing G corresponding to position 65 with R to obtain the mutant G65R, or, [0093] replacing E corresponding to position 282 of SEQ ID NO: 1 with L to obtain the mutant E282L, or, [0094] replacing G corresponding to position 365 of SEQ ID NO: 1 with D to obtain the mutant G365D, [0095] replacing D corresponding to position 133 of SEQ ID NO: 1 with E to obtain the mutant D133E, or [0096] replacing R corresponding to position 382 of SEQ ID NO: 1 with I to obtain the mutant R382I, or, [0097] replacing S corresponding to position 393 of SEQ ID NO: 1 with I to obtain the mutant S393I.
[0098] Thirdly, the amino acid sequence of phytase APPAmut4 derived from Yersinia intermedia was performed the mutations of replacing A corresponding to position 57, A corresponding to position 103, G corresponding to position 101, V corresponding to position 116, R corresponding to position 271, E corresponding to position 413, R corresponding to position 353, L corresponding to position 401, A corresponding to position 147, Y corresponding to position 268 of SEQ ID NO: 1 with C respectively, to obtain the mutant APPAmut5.
[0099] Fourthly, the amino acid sequence of the APPAmut5 was performed the additional mutations of replacing G corresponding to position 65 with R, E corresponding to position 282 with L, and G corresponding to position 365 with D, using the primers for the site directed mutagenesis, to obtain the mutant APPAmut8.
[0100] Fifthly, the amino acid sequence of the APPAmut8 was performed the additional mutations of replacing D corresponding to position 133 with E, R corresponding to position 382 with I, and S corresponding to position 393 with I using the primers for the site directed mutagenesis to obtain the mutant APPAmut9.
TABLE-US-00001 TABLE2 primersforthesitedirectedmutagenesis Primer Sequenceoftheprimers(5-3) A147C-F ACCCACAAATGTGTTGAAGAGAG Y268C-R TCTAGCAATACAAGGAGTCTTTG R271C-F TACATTGCTTGTCACAAAGGAACTC E413C-R ACAAGCTGGACATATGGCCTGAGCAACC G101C-R TCCTGGAGCGATACCATCCAAGAATGCTTGACAGGTCA AACGAGTTC V116C-F TTCTTGGATGGTATCGCTCCAGGATGTGGCTTGAAATG TCACTACCAGG A57C-F CACCAAGAGGTTGTCAGTTGGTTAC A103C-R CATCCAAGAAACATTGTCCGGTCAAAC R353C-F CAACCACCAGTGTTACGTTGCTGTAAAG L401C-R GAAAGTATCACACTGGCACAAC R353C-R AGCAACGTAACACTGGTGGTTGTCAGGGTTTTGC L401C-F GCCAGTGTGATACTTTCCAGAAGAAGG G365D-F CAGACTATGGATCAATTGCGTAACGCAGAG G365D-R CGCAATTGATCCATAGTCTGATAGAACAAC A89V-F GACATCTACGTTCAAGCTGACGTTGATCAAAG A89V-R GTCAGCTTGAACGTAGATGTCAGCATCAGTAG G65R-F ATGGGTAGATTCTACGGTGACTATTTCAG G65R-R ACCGTAGAATCTACCCATCAAAGTAACCAAC E282L-F CAGCAAATCTTGACTGCTTTGGTCCTCCAAAG E282L-R CAAAGCAGTCAAGATTTGCTGAAGCAAGGGAG D133E-F CACCCTGTTGAAGCAGGTGTTTGTAAGCTTG D133E-R AAACACCTGCTTCAACAGGGTGGAACAGTGG R382I-F CCAGCCGGTATTGTTCCTGTCGCAATTGACG R382I-R GACAGGAACAATACCGGCTGGGTTGTTCTTC S393I-F TGTGAGAACATTGGAGATGACAAGTTGTGCC S393I-R GTCATCTCCAATGTTCTCACAACCGTCAATTG
Example 2 Constructing the Strain Expressing the Phytase APPAmut4 and its Mutants
[0101] PCR amplification was performed using primers containing the corresponding mutation sites and plasmid pPICZA-appamut4 as the template, and then the PCR amplification product was analyzed by 1% agarose gel electrophoresis, wherein If the size of the band was consistent with the theoretical value, the PCR reaction was successful in obtaining the target product. In order to eliminate the interference of template plasmids on subsequent experiments, 1 L of restriction enzyme Dpn I was added to the PCR system based on the methylation difference between template plasmids and PCR products, followed by being digested at 37 C. for 1 to 2 hours. Then, 10 L of the product was transformed into E. coli DMT competent cells, followed by extracting the recombinant plasmid when the result of sequencing is correct, linearizing it using the restriction enzyme Pme I, purifying and recovering the product, and transforming it into the competent cells of Pichia pastoris GS115 to obtain the recombinant expression strain of Pichia pastoris.
Example 3 Preparing the Phytase APPAmut4 and its Mutant
[0102] The obtained recombinant expression strain was inoculated into YPD medium for seed culture at 200 rpm and 30 C. for 48 hours, followed by being transferred to BMGY medium in 1% inoculation amount and cultured at 200 rpm and 30 C. for 48 hours. Then, the supernatant was discard after being centrifuged at 4500 rpm for 5 minutes, the bacterial cells were collected, and BMMY medium containing 0.5% of methanol was added for inducing the expression with a addition of 0.5% of methanol every 12 hours for a total of 48 hours of induction.
[0103] The induced bacterial solution was centrifuged at 12000 rpm for 10 minutes, to collect the supernatant for concentration, followed by being dialyzed with 20 mM of Tris HCl at pH 8.0. Then, the dialyzed enzyme solution was subjected to anion exchange chromatography, with the solution A containing 20 mM of Tris HCL at pH 8.0 and the solution B obtained by adding 1 M of NaCL to the solution A, to purify the protein, and the eluent was collected for SDS-PAGE analysis.
Example 4 Measuring the Enzymatic Properties of Mutants
(1) Determining the Optimal Temperature
[0104] The enzyme activity of wild-type and mutant was measured at the different temperatures of 30 C., 35 C., 40 C., 45 C., 50 C., 55 C. C, 60 C., 65 C., and 70 C. with 0.1 mol/L of HAc NaAc buffer at pH to determine the optimal temperature, wherein the activity corresponding to the optimal temperature was defined as 100%, and the remaining enzyme activity at the other temperatures was calculated. As shown in
(2) Measuring the Thermal Stability
[0105] The purified protein was diluted with 0.1 mol/L of HAc NaAc buffer in pH 5.5 containing 0.05% BSA and 0.05% Triton X-100 to an appropriate multiple, followed by taking 100 L for being incubated at 65 C. for 0, 2, 5, 10, 15, and 30 min respectively, and then measuring the corresponding enzyme activity, wherein the activity at 0 min is considered as 100%, and the remaining enzyme activities at different incubation time were calculated respectively.
[0106] As shown in
[0107] Half life t.sub.1/2 refers to the time that takes for the initial activity to decrease by 50% at a given temperature, and was calculated by the following formula,
[0110] As shown in
(3) Determination of Dynamic Parameters
[0111] The different concentrations of sodium phytate ranging from 0.05 to 1.00 mM were prepared as substrates and the activity of phytase was measured at 37 C. and pH 5.5, wherein the software GraphPad Prism was used for data processing, and the values of K.sub.m and k.sub.cat were calculated. As shown in Table 2, the value of K.sub.m of the phytase APPAmut4 is 0.14 mM, while the values of K.sub.m of the mutants A57C/A103C, G101C/V16C, A147C/Y268C, R271C/E413C, R353C/L401C, and G65R have increased in the varying degrees ranging from 0.18 to 0.22, indicating a decrease in substrate affinity. The catalytic efficiency k.sub.cat/K.sub.m of the phytase APPAmut4 was 12322/mM/s, while the k.sub.cat/K.sub.m of the mutants A147C/Y268C and G65R decreased to 10823 and 9009/mM/s, respectively, indicating that the mutation affected its catalytic activity, and the catalytic efficiency of the remaining single point and double point mutants remains unchanged or slightly improves. The k.sub.cat/K.sub.m for the combination mutants APPAmut5, APPAmut8, and APPAmut9 are 11632, 13018, and 11537/mM/s, which remained relatively unchanged as compared to the phytase APPAmut4, respectively, indicating that a significant the improvement in thermal stability didn't reduce their catalytic efficiency.
TABLE-US-00002 TABLE 2 Dynamics parameters of the phytase APPAmut4 and its mutants Enzymes K.sub.m (mM) V.sub.max (mol/min/mg) k.sub.cat (/s) k.sub.cat/K.sub.m (/mM/s) APPAmut4 0.14 0.03 2272 95 1725 72 12322 1577 A57C/A103C 0.18 0.03 2845 171 2160 130 12068 1368 G101C/V116C 0.20 0.03 2932 157 2226 119 11131 1132 A147C/Y268C 0.22 0.03 3136 163 2381 124 10823 1019 R271C/E413C 0.18 0.03 3177 203 2412 154 13402 1545 R353C/L401C 0.20 0.02 3400 163 2581 124 12908 955 G65R 0.22 0.04 2634 101 2000 77 9009 992 E282L 0.15 0.02 2300 88 1746 67 11269 967 G365D 0.14 0.02 2411 76 1831 58 13158 1148 D133E 0.13 0.03 2477 76 1881 58 14989 1960 R382I 0.16 0.02 2564 106 1947 80 11958 993 S393I 0.14 0.03 2772 126 2105 96 14716 1912 APPAmut5 0.15 0.02 2298 108 1744 82 11632 1048 APPAmut8 0.15 0.02 2630 127 1997 96 13018 1181 APPAmut9 0.15 0.02 2279 134 1730 102 11537 1109.
[0112] The above embodiments are only used to illustrate the technical solution of the present application and do not limit the scope of protection of the present application.